Skip to content

Firm News

Sichenzia Ross Ference Carmel LLP Represents High Roller Technologies, Inc. in $25 Million Registered Direct Offering

January 22, 2026

Sichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025

January 20, 2026

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics in $30 Million Public Offering

January 15, 2026

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $8 Million Registered Direct Offering and Private Placement of Estrella Immunopharma

January 8, 2026

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities and American Ventures in $20 Million ELOC and $3 Million Private Placement of MMA.INC

January 6, 2026

Sichenzia Ross Ference Carmel LLP Obtains Dismissal Of Petition For Construction Of Will; Extends Precedent to Third Department, And Obtains Resolution In Favor Of IRA Custodian And Account’s Beneficiaries

January 5, 2026

Sichenzia Ross Ference Carmel LLP Represents Lixte Biotechnology in $4.3 Million Registered Direct Offering

December 19, 2025

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $20 Million Underwritten Public Offering of Aduro Clean Technologies

December 19, 2025

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in Financing Arrangements for Up to $180 Million of Robo.ai Inc.

December 19, 2025

Sichenzia Ross Ference Carmel LLP Represents Avalon GloboCare in its Acquisition of RPM Interactive

December 17, 2025

Sichenzia Ross Ference Carmel LLP Represents Jiuzi Holdings in $4 Million Registered Direct Offering

December 17, 2025

Sichenzia Ross Ference Carmel LLP Represents Lexaria Bioscience Corp. in $3.5 Million Registered Direct Offering

December 17, 2025

Sichenzia Ross Ference Carmel LLP Provides 2025 Firm Update and Introduces Re-Designed Firm Website

December 15, 2025

Sichenzia Ross Ference Carmel LLP Represents Treasure Global in $2.5 Million Registered Direct Offering

December 15, 2025

Sichenzia Ross Ference Carmel LLP Represents Virax Biolabs Group Limited in $5 Million Private Placement

December 9, 2025

Sichenzia Ross Ference Carmel LLP Represents JonesTrading in $100 Million At-the-Market Offering of Armata Pharmaceuticals

December 8, 2025

Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners in $113.5 Million Private Placement of SMX

December 4, 2025

Sichenzia Ross Ference Carmel LLP Represents FibroBiologics, Inc., in $1.5 Million Registered Direct Offering and Concurrent Private Placement

December 2, 2025

Sichenzia Ross Ference Carmel LLP Represents FibroBiologics, Inc., in $4 Million Registered Direct Offering and Concurrent Private Placement with Purchase Price Paid in Gold

December 2, 2025

Sichenzia Ross Ference Carmel LLP Recognized in 2026 Chambers USA New York Spotlight Guide for Securities Transactions and Securities Litigation

December 2, 2025

Sichenzia Ross Ference Carmel LLP Represents LIXTE Biotechnology in its Acquisition of Liora Technologies

November 26, 2025